Lv43
670 积分 2023-04-18 加入
Anti-obesity weight loss medications: Short-term and long-term use
1天前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
6天前
已完结
Real‐World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study
6天前
已关闭
American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease – 2025 Update
6天前
已完结
中国肥胖及代谢疾病外科治疗指南（2024版）
7天前
已完结
Fatty liver index (FLI): more than a marker of hepatic steatosis
12天前
已完结
The global burden of metabolic disease: Data from 2000 to 2019
13天前
已完结
High prevalence of obesity-related hypertension among adults aged 40 to 79 years in Southwest China
26天前
已关闭
Treating the invisible: moving towards more personalized stroke care
1个月前
已关闭
皖公网安备34019202002308
